Article Sidebar

pdf
Date Published: 31/12/2025
Abstract Views: 43
Views pdf: 36
DOI: https://doi.org/10.51298/vmj.v557i2.16707
Issue
Vol. 557 No. 2 (2025)
Section
Các bài báo
How to Cite
Lê, V. V., Phạm, H. K., & Nguyễn, X. T. (2025). EVALUATION OF THE EFFICACY OF A VESSEL-SEALING DEVICE IN TOTAL MASTECTOMY WITH AXILLARY LYMPH NODE DISSECTION. Vietnam Medical Journal, 557(2). https://doi.org/10.51298/vmj.v557i2.16707

EVALUATION OF THE EFFICACY OF A VESSEL-SEALING DEVICE IN TOTAL MASTECTOMY WITH AXILLARY LYMPH NODE DISSECTION

Văn Vũ Lê, Hồng Khoa Phạm, Xuân Tuấn Nguyễn

Main Article Content

Abstract

Background: Total mastectomy with axillary lymph node dissection is a standard surgical procedure in the management of breast cancer. Conventional electrocautery is widely applied but remains associated with several limitations, including higher rates of seroma formation, increased postoperative pain, and prolonged recovery. Advanced vessel-sealing technology provides improved hemostasis and may reduce complications while enhancing surgical outcomes. Objective: To assess the efficacy of an advanced vessel-sealing device compared with conventional electrocautery in total mastectomy with axillary lymph node dissection for breast cancer. Patients and Methods: A retrospective descriptive study was conducted on 138 patients with stage II–III breast cancer treated at K Hospital from June 2023 to June 2025. Patients were allocated into two groups: Group A (conventional electrocautery, n = 62) and Group B (vessel-sealing device, n = 76). Outcomes evaluated included operative time, intraoperative blood loss, postoperative pain (VAS), drain output, skin flap necrosis, and length of hospital stay. Results: The vessel-sealing device group showed significant advantages over conventional electrocautery: shorter operative time (57.1 ± 11.2 vs. 78.5 ± 18.9 minutes; p < 0.0001), reduced blood loss (88.5 ± 29.8 vs. 115.4 ± 31.3 mL; p < 0.0001), lower postoperative pain (VAS 3.5 ± 0.9 vs. 5.1 ± 0.8; p < 0.0001), reduced drain output during the first 72 hours (310.6 ± 95.2 vs. 520.3 ± 110.5 mL; p < 0.0001), and earlier drain removal (5.1 ± 0.9 vs. 6.2 ± 1.1 days; p < 0.0001). The mean hospital stay was shorter in the vessel-sealing group (5.3 ± 1.0 vs. 6.8 ± 1.2 days; p < 0.0001). No significant differences were observed in complication rates, including skin flap necrosis (3.9% vs. 4.8%; p > 0.05). Conclusion: The application of an advanced vessel sealing device in total mastectomy with axillary lymph node dissection effectively reduces operative time, intraoperative blood loss, postoperative pain, drain output, and hospital stay, without increasing complications.

Article Details

Keywords

breast cancer, total mastectomy, vessel sealing device, axillary lymph node dissection

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
2. Shaikh IA, Khan AA, Butt UI, Ahmed M, Ali A, Shah M, et al. Comparison of vessel sealing system versus conventional electrocautery in modified radical mastectomy. Breast J. 2021;27(3):222–8.
3. Cortadellas T, Córdoba O, Fuster M, Muñoz-Casares C, de la Torre J, Bascuñana J, et al. LigaSure versus conventional electrocautery in axillary lymphadenectomy for breast cancer: a prospective randomized clinical trial. Breast Cancer Res Treat. 2011;128(2):353–8.
4. Seki T, Hachiya K, Morimoto T, Sato K, Hirano A, Kimura Y, et al. The use of LigaSure vessel sealing system in axillary lymph node dissection for breast cancer. Breast Cancer. 2016;23(2):237–41.
5. Chang YW, Kim HJ, Park BW, Kim SJ. The effectiveness of the LigaSure vessel sealing system in axillary lymph node dissection for breast cancer: a prospective randomized controlled study. World J Surg Oncol. 2017;15:146.
6. Panhofer P, Riedl O, Dubsky P, Hochreiner G, Dubsky PC, Jakesz R, et al. Impact of vessel sealing systems in axillary lymph node dissection for breast cancer. Eur Surg Res. 2015;54(1-2):1–8.
7. Botoncea M, Stanculeanu DL, Cursaru A, Anghel RM. LigaSure versus conventional surgery in axillary dissection for breast cancer: a prospective randomized study. Chirurgia (Bucur). 2019;114(2):192–8.
8. Antonio M, Gómez R, Tresserra F, Fusté F, Izquierdo M, Grases PJ. Axillary dissection in breast cancer surgery: harmonic scalpel versus electrocautery. Eur J Surg Oncol. 2007;33(3):339–43.
9. Macario A, Dexter F, Vitez TS, Hunter TD, Escobar A. Meta-analysis of studies comparing LigaSure vessel sealing system with standard surgical techniques. Arch Surg. 2008;143(3):279–86.
10. Manouras A, Markogiannakis H, Genetzakis M, Lagoudianakis E, Papadima A, Kafiri G, et al. Modified radical mastectomy with axillary dissection using the LigaSure vessel sealing system. Arch Surg. 2008;143(6):575–80.